REQUEST A DEMO
Total
USD $0.00
Search more companies

Saphiropharma T. Bartoszuk, R. Kucikowicz sp. j. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmacies and Drug Stores
Full name: Saphiropharma T. Bartoszuk, R. Kucikowicz sp. j. Profile Updated: June 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Saphiropharma T. Bartoszuk, R. Kucikowicz sp. j. is a company based in Poland, with its head office in Warsaw. The company operates in the Department Stores industry. The company was established on November 09, 2021. Its total assets decreased by 32.79% over the same period.

Headquarters
Ul. Aleje Jerozolimskie 89/43
Warsaw; Mazowieckie; Postal Code: 02-001

Contact Details: Purchase the Saphiropharma T. Bartoszuk, R. Kucikowicz sp. j. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Saphiropharma T. Bartoszuk, R. Kucikowicz sp. j. report to view the information.
Incorporation Date:
November 09, 2021
Key Executives
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Associate
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Saphiropharma T. Bartoszuk, R. Kucikowicz sp. j. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-134.17%
Net Profit (Loss) for the Period
-108.68%
Total assets
-32.79%
Total equity
-210.52%
Return on Equity (ROE)
-33.08%
Debt to Equity Ratio
393.69%
Quick Ratio
-9.87%
Cash Ratio
-8.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?